started · updated
University of Cambridge researchers develop mRNA therapy to repair heart tissue
Scientists at the University of Cambridge have developed an experimental gene therapy using messenger RNA (mRNA) that enables heart muscle cells to repair damage following a myocardial infarction. The study, published in Nature Cardiovascular Research, focuses on reactivating the regenerative capacity of cardiac muscle cells.
In mouse models, the treatment temporarily activates two specific proteins, Myc and Cyclin T1, which triggers the cells to divide and repair damaged tissue. The experimental therapy resulted in a nearly 10% increase in the amount of blood pumped per heartbeat compared to a control group, with the effects sustained for 12 weeks.
While the results are considered a significant step toward addressing heart failure, the therapy remains in the experimental stage and has not yet been tested in humans.